SCHEMBL8285337

SCHEMBL8285337

Cc1cc2c(c(SCC(=O)N3CCOCC3)n1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.47
HSP90AB1 P08238 1/20 0.47
ALDH1A1 P00352 7/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
KMT2A Q03164 4/20 0.46
MEN1 O00255 2/20 0.46
PDE11A Q9HCR9 1/20 0.45
MAPT P10636 2/20 0.44
TSHR P16473 2/20 0.44
POLB P06746 4/20 0.43
GAA P10253 1/20 0.43
PKM P14618 1/20 0.42
FKBP1A P62942 1/20 0.42
KDM4E B2RXH2 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MAPK1 P28482 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5872104 0.86 GAA (0.45) SMN1; SMN2KMT2APDE11APOLBGAA
SCHEMBL8287419 0.85 PDE11A (0.51) HSP90AA1HSP90AB1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL8286558 0.84 PDE11A (0.46) HSP90AA1HSP90AB1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL8286548 0.83 SMN1; SMN2 (0.50) SMN1; SMN2KMT2AMAPTTSHRPOLB
SCHEMBL8285340 0.83 PDE11A (0.45) ALDH1A1SMN1; SMN2PDE11AMAPTGAA
SCHEMBL8286039 0.82 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2KMT2AMEN1MAPT
SCHEMBL5872280 0.81 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2KMT2AMEN1GAA
SCHEMBL7036674 0.81 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2PDE11AMAPTGAA
SCHEMBL8287221 0.79 APLNR (0.42) ALDH1A1SMN1; SMN2PDE11AMAPTTSHR
SCHEMBL8287403 0.79 PDE11A (0.56) ALDH1A1SMN1; SMN2PDE11AMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed